Decreasing in-hospital mortality of patients undergoing percutaneous coronary intervention with persistent higher mortality rates in women and minorities in the United States

Journal of Invasive Cardiology

Volumn 22, Issue 2, 2010, Pages 58-60

  Movahed, Mohammad Reza ^a   Hashemzadeh, Mehrtash ^b   Jamal, M Mazen ^b   Ramaraj, Radhakrishnan ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

Angioplasty; Cardiovascular disease; Coronary artery disease; Epidemiology; Incident; Prevalence; Stent

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DRUG ELUTING STENT; ETHNIC DIFFERENCE; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINORITY GROUP; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; SEX DIFFERENCE; TRANSLUMINAL CORONARY ANGIOPLASTY; WOMEN'S HEALTH;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY DISEASE; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; MINORITY GROUPS; PREVALENCE; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; UNITED STATES;

EID: 76749106123     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733-742.
2. Hassapoyannes CA, Giurgiutiu DV, Eaves G, Movahed MR. Apparent racial disparity in the utilization of invasive testing for risk assessment of cardiac patients undergoing noncardiac surgery. Cardiovasc Revasc Med 2006;7:64-69.
3. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
4. Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 2006;27:779-788.
5. Le May MR, Davies RF, Labinaz M, et al. Hospitalization costs of primary stenting versus thrombolysis in acute myocardial infarction: Cost analysis of the Canadian STAT Study. Circulation 2003;108:2624-2630.
6. Movahed MR, Ramaraj R, Jamal MM, Hashemzadeh M. Nationwide trends in the utilization of multivessel percutaneous coronary intervention (MVPCI) in the United States across different gender and ethnicities. J Interv Cardiol 2009;22:247-251.
7. Movahed MR, Ramaraj R, Jamal MM, Hashemzadeh M. Decline in the nationwide trends in in-hospital mortality of patients undergoing multivessel percutaneous coronary intervention. J Invasive Cardiol 2009;21:388-390.
8. Movahed MR, Ramaraj R, Jamal MM, Hashemzadeh M. Nationwide trends in the utilisation of percutaneous coronary intervention (PCI) in the United States of America based on gender and ethnicities. EuroIntervention 2009;5:343-348.
9. HCaUiP (2002) Nationwide Inpatient Sample (NIS): Agency for Healthcare Research and Quality R, MD.
10. Alexander D, Ou FS, Roe MT, et al. Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: Results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE). Am Heart J 2008;156:606-612.
11. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour. Lancet 1996;348:771-775.
12. Blackledge HM, Squire IB. Improving long-term outcomes following coronary artery bypass graft or percutaneous coronary revascularisation: Results from a large, population- based cohort with first intervention 1995-2004. Heart 2009;95:304-311.
13. Singh M, Rihal CS, Gersh BJ, et al. Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience. J Am Coll Cardiol 2008;51:2313-2320.
14. Singh M, Peterson ED, Roe MT, et al. Trends in the association between age and inhospital mortality after percutaneous coronary intervention: National Cardiovascular Data Registry Experience. Circ Cardiovasc Intervent 2009;2:20-26.
15. Lavi S, Gruberg L, Kapeliovich M, et al. The impact of GP IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction patients. J Invasive Cardiol 2005;17:296-299.
16. Nikolsky E, Holmes DR, Mehran R, et al. Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents. Catheter Cardiovasc Interv 2008;71:896-906.
17. Marmur JD, Poludasu S, Lazar J, Cavusoglu E. Long-term mortality after bolus-only administration of abciximab, eptifibatide, or tirofiban during percutaneous coronary intervention. Catheter Cardiovasc Interv 2009;73:214-221.
18. Ortolani P, Marzocchi A, Marrozzini C, et al. Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: Results of a registry study in an ST-elevation myocardial infarction network. Eur Heart J 2009;30:33-43.
19. Chase AJ, Fretz EB, Warburton WP, et al. Association of the arterial access site at angioplasty with transfusion and mortality: The MORTAL study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg). Heart 2008;94:1019-1025.
20. Helft G, Dambrin G, Zaman A, et al. Percutaneous coronary intervention in anticoagulated patients via radial artery access. Catheter Cardiovasc Interv 2009;73:44-47.
21. Jolly SS, Amlani S, Hamon M, et al. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials. Am Heart J 2009;157:132-140.
22. Lev EI, Kornowski R, Vaknin-Assa H, et al. Effect of clopidogrel pretreatment on angiographic and clinical outcomes in patients undergoing primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. Am J Cardiol 2008;101:435-439.
23. Moore RK, Lowe R, Grayson AD, et al. A study comparing the incidence and predictors of creatine kinase MB and troponin T release after coronary angioplasty. Does clopidogrel preloading reduce myocardial necrosis following elective percutaneous coronary intervention? Int J Cardiol 2007;116:93-97.
24. White HD. HORIZONS trial: A step forward for primary percutaneous coronary intervention. Expert Rev Cardiovasc Ther 2009;7:125-129.
25. White HD, Ohman EM, Lincoff AM, et al. Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol 2008;52:807-814.
26. Movahed MR, John J, Hashemzadeh M, et al. Trends in the age-adjusted mortality from acute ST segment elevation myocardial infarction in the United States (1988-2004) based on race, gender, infarct location and comorbidities. Am J Cardiol 2009;104:1030-1034.